Funded Tech Companies
StrideBio
StrideBio, based in Research Triangle Park, received investment capital from Takeda Ventures, Sarepta Therapeutics and Alexandria Venture Investments.
Company Overview
Company Name
StrideBio
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
5 Laboratory Dr. 1200
Research Triangle Park, NC 27709
USA
Research Triangle Park, NC 27709
USA
Phone
Website
Email Address
Company Background Information
Overview
StrideBio, Inc. is a gene therapy company focused on creating and developing novel adeno-associated viral (AAV) vector technologies. Our STRucture Inspired DEsign approach holds the potential to generate unique AAV capsids capable of overcoming the challenges of pre-existing neutralizing antibodies in patients.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
3/17/2021
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sapan Shah
Chief Operating Officer
William Monteith
Chief Scientific Officer
Aravind Asokan
Co-Founder
Mavis Agbandje
Co-Founder
Patrick Ritschel
VP - Bus. Development
Maritza McIntyre
VP - Finance
Robert Hughes
VP - Operations
Ariane Hamaide
Company Investors
- Takeda Ventures (Jayson Punwani)
- Sarepta Therapeutics
- Alexandria Venture Investments
- UCB S.A. (Erica Whittaker)
- Pontifax Fund
- Novo Ventures (Karen Hong)
- Octagon Investments Fund
- Hatteras Venture Partners (Clay Thorp)
- CaaS Capital Management
- Northpond Ventures (Shaan Gandhi)
- University of Florida
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs